Interestingly, RT + ATRi significantly reduced PD-L2 expression in HPV-positive HNSCC cell lines compared to single RT treatment, while having no significant impact on PD-L2 expression in HPV-negative HNSCC cells. Here, PDCD1LG2 is linked to head and neck squamous cell carcinoma.